Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials). The product was ...
Alembic is introducing Docetaxel injection, 20 mg/2 ml (10 mg/ml), 80 mg/8 ml (10 mg/ml) and 160 mg/16 ml (10 mg/ml), which is the generic of Hospira’s Docetaxel injection. Docetaxel injection is a ...
Amid a shortage of standard-of-care chemotherapy drugs, Sagent Pharmaceuticals is pulling two lots of its docetaxel injection from U.S. shelves after receiving a report of potential particulate matter ...
The U.S. Food and Drug Administration (FDA) has approved Teikoku Pharma USA's nonalcohol docetaxel injection for the treatment of head and neck cancer, breast cancer, non-small cell lung cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results